Deficiency of the p53/p63 target Perp alters mammary gland homeostasis and promotes cancer

por Dusek, Rachel L, Bascom, Jamie L, Vogel, Hannes, Baron, Sylvain, Borowsky, Alexander D, Bissell, Mina J, Attardi, Laura D
Publicado 2012

Desmoglein 1–dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis

por Getsios, Spiro, Simpson, Cory L., Kojima, Shin-ichiro, Harmon, Robert, Sheu, Linda J., Dusek, Rachel L., Cornwell, Mona, Green, Kathleen J.
Publicado 2009

Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis

por Beaudry, Veronica G., Jiang, Dadi, Dusek, Rachel L., Park, Eunice J., Knezevich, Stevan, Ridd, Katie, Vogel, Hannes, Bastian, Boris C., Attardi, Laura D.
Publicado 2010

Targeting CD157 in AML using a novel, Fc-engineered antibody construct

por Krupka, Christina, Lichtenegger, Felix S., Köhnke, Thomas, Bögeholz, Jan, Bücklein, Veit, Roiss, Michael, Altmann, Torben, Do, To Uyen, Dusek, Rachel, Wilson, Keith, Bisht, Arnima, Terrett, Jon, Aud, Dee, Pombo-Villar, Esteban, Rohlff, Christian, Hiddemann, Wolfgang, Subklewe, Marion
Publicado 2017

Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models

por Gaudio, Eugenio, Tarantelli, Chiara, Spriano, Filippo, Guidetti, Francesca, Sartori, Giulio, Bordone, Roberta, Arribas, Alberto J., Cascione, Luciano, Bigioni, Mario, Merlino, Giuseppe, Fiascarelli, Alessio, Bressan, Alessandro, Mensah, Afua Adjeiwaa, Golino, Gaetanina, Lucchini, Renzo, Bernasconi, Elena, Rossi, Davide, Zucca, Emanuele, Stussi, Georg, Stathis, Anastasios, Boyd, Robert S., Dusek, Rachel L., Bisht, Arnima, Attanasio, Nickolas, Rohlff, Christian, Pellacani, Andrea, Binaschi, Monica, Bertoni, Francesco
Publicado 2020